O'Sullivan Brian P, Zwerdling Robert G, Dorkin Henry L, Comeau Anne Marie, Parad Richard
Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA.
Pediatrics. 2006 Sep;118(3):1260-5. doi: 10.1542/peds.2006-0399.
We report 3 cystic fibrosis newborn screen-positive infants with the DeltaF508/R117H-7T genotype who had Pseudomonas aeruginosa detected in oropharyngeal cultures early in life and a fourth who had pulmonary symptoms and Gram-negative growth on multiple oropharyngeal cultures. All 4 patients were followed prospectively from the time of genetic diagnosis. As many regions implement newborn screening for cystic fibrosis, there is concern regarding which mutations should be included in genetic panels used to make the cystic fibrosis diagnosis. Some have recommended that mutations not specifically associated with classic cystic fibrosis be excluded. Our cases highlight the importance of considering keeping so-called mild mutations on cystic fibrosis newborn screening panels and the need to follow children with these mutations closely.
我们报告了3例患有DeltaF508/R117H-7T基因型的囊性纤维化新生儿筛查呈阳性的婴儿,他们在生命早期的口咽培养物中检测到铜绿假单胞菌,还有第4例婴儿有肺部症状且多次口咽培养物中出现革兰氏阴性菌生长。所有4例患者从基因诊断时起就进行了前瞻性随访。随着许多地区开展囊性纤维化新生儿筛查,人们担心用于囊性纤维化诊断的基因检测板应包括哪些突变。一些人建议排除与经典囊性纤维化无特异性关联的突变。我们的病例强调了在囊性纤维化新生儿筛查检测板上考虑保留所谓轻度突变的重要性,以及密切随访携带这些突变儿童的必要性。